Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for Resectable Hepatic Metastasis from GIST
NCT00764595Phase 2Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Oct 2008
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Translational Research Center for Medical Innovation. Started Oct 2008; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00764595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764595.